3M Company
3M Company (USA) holds 1 active US FDA Type II Drug Master File and holds 1 active Type IV (excipient) Drug Master File. 26 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “3M Company: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/3m-company
Overview
3M Drug Delivery Systems is a subsidiary of 3M Company, focusing on the innovation and development of advanced drug delivery technologies. The company provides expertise in inhalation, transdermal, and microstructured transdermal systems to enhance the effectiveness and safety of medications.
Core services & business areas
Therapeutic areas
API / Drug Master Files
3M Company holds 1 active (1 total) FDA Type II Drug Master File. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- FLURANDRENOLIDE DRUG-IN-ADHESIVE R-2813Active2024-01-17
Excipient Drug Master Files
3M Company holds 1 active (1 total) FDA Type IV Drug Master File. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.
- SOLVATED ACRYLATE COPOLYMER ADHESIVE R-24449Active2010-12-22
FDA compliance signals
26 FDA enforcement records linked to this company.
- 4832024-09-06
Valid stability test methods
- 4832024-09-06
Computer control of master formula records
- 4832020-03-20
Contamination, chemical or physical change, deterioration
- 4832020-03-20
Procedures not in writing, fully followed
- 4832020-03-20
Calibration/Inspection/Checking not done
- 4832020-03-20
Written distribution procedure
- 4832019-02-11
Failure to report non-alert ADEs
- 4832018-05-25
Complete Test Data
- 4832018-05-25
Procedures not in writing, fully followed
- 4832018-05-25
input/output verification
- 4832018-05-25
Component identity verification
- 4832017-05-17
Failure to develop written procedures
- 4832017-05-17
Timing of AE report submission (non-RX drugs)
- 4832017-05-17
No label copy submitted with AE report (non-Rx drug)
- 4832017-05-17
New medical information, timing of submission (non-Rx drugs)
- 4832017-05-17
Timely submission
- 4832017-05-17
Form FDA 2252
- 4832017-05-17
Failure to maintain records
- 4832017-05-17
Late submission of annual safety reports
- 4832014-12-15
Procedures not in writing, fully followed
- 4832014-12-15
Investigations of discrepancies, failures
- 4832014-12-15
Failure to meet specifications
- 4832011-04-13
Procedures not in writing, fully followed
- 4832011-04-13
Reprocessing procedures lack steps to be taken
- 4832011-04-13
Weighing/measuring/subdividing supervision
- 4832011-04-13
No written record of investigation
Is this 3M Company?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.